Aemetis Stock Gets Increased EPS Estimate from HC Wainwright

Aemetis, Inc (NASDAQ:AMTX) – Investment analysts at HC Wainwright upped their FY2026 earnings per share (EPS) estimates for Aemetis in a research note issued to investors on Friday, November 6th. HC Wainwright analyst A. Dayal now forecasts that the specialty chemicals company will post earnings per share of ($0.55) for the year, up from their prior estimate of ($0.88). The consensus estimate for Aemetis’ current full-year earnings is ($0.89) per share. HC Wainwright also issued estimates for Aemetis’ Q4 2026 earnings at ($0.16) EPS, FY2027 earnings at ($0.28) EPS, FY2028 earnings at $0.74 EPS and FY2029 earnings at $2.15 EPS.

Aemetis (NASDAQ:AMTX) last posted its earnings results on Thursday, November 5th. The specialty chemicals company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.18. The firm had revenue of $88.15 million during the quarter, compared to the consensus estimate of $74.20 million.

Other analysts have also recently issued reports about the stock. Wall Street Zen raised shares of Aemetis from a “sell” rating to a “hold” rating in a research note on Saturday, August 22nd. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aemetis in a research note on Thursday, October 15th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $11.88.

Aemetis Stock Up 6.8%

Shares of AMTX stock opened at $1.73 on Tuesday. Aemetis has a 12-month low of $1.11 and a 12-month high of $3.80. The company has a market capitalization of $124.85 million, a P/E ratio of -3.09 and a beta of 1.87. The firm has a 50-day moving average price of $1.66 and a 200 day moving average price of $1.95.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. Royal Bank of Canada raised its position in shares of Aemetis by 10,632.5% during the first quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company’s stock worth $28,000 after acquiring an additional 8,825 shares during the last quarter. Sanctuary Advisors LLC bought a new position in Aemetis in the first quarter valued at about $33,000. R Squared Ltd boosted its holdings in Aemetis by 59.4% in the third quarter. R Squared Ltd now owns 23,616 shares of the specialty chemicals company’s stock valued at $42,000 after acquiring an additional 8,803 shares during the last quarter. Lido Advisors LLC bought a new position in Aemetis in the third quarter valued at about $79,000. Finally, State of Wyoming acquired a new stake in Aemetis in the third quarter worth about $226,000. 27.02% of the stock is currently owned by institutional investors.

Aemetis Company Profile

Aemetis, Inc is a renewable fuels and carbon-reduction company that develops and operates projects designed to produce lower-carbon alternatives to petroleum-based fuels and reduce greenhouse-gas emissions. Its activities include renewable natural gas, ethanol, renewable diesel, and other advanced fuel technologies.

The company’s California operations include dairy-based renewable natural gas projects that capture methane from dairy waste and convert it into pipeline-quality fuel. Aemetis also operates an ethanol production facility in Keyes, California, which produces ethanol and related co-products from agricultural feedstocks.